Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients

NCT02221999 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

250

Enrollment

OTHER

Sponsor class

Conditions

Tubular Breast Cancer
Mucinous Breast Cancer
Invasive Ductal Breast Cancer
Inflammatory Breast Cancer

Interventions

DRUG: Paclitaxel
DRUG: Cisplatin
DRUG: Gonadotropin-releasing hormone agonist
DRUG: Letrozole

Sponsor

RenJi Hospital